HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024

Rhea-AI Summary

Harmony Biosciences Holdings (Nasdaq: HRMY) has announced that it will release its second quarter 2024 financial results on Tuesday, August 6, 2024, before the U.S. financial markets open. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. Interested parties can participate in the call by dialing (800) 225-9448 (domestic) or (203) 518-9708 (international) and using the passcode HRMYQ224. It is advised to dial in at least 10 minutes before the call starts. A live and replay webcast of the call will be available on the investor page of Harmony Biosciences' website.

News Market Reaction

+0.15%

1 alert

+0.15% News Effect

On the day this news was published, HRMY gained 0.15%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PLYMOUTH MEETING, Pa., July 23, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2024 financial results on Tuesday, August 6, 2024, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on August 6, 2024, at 8:30 a.m. ET to discuss the results.

To participate in the call, please dial (800) 225-9448 (domestic) or (203) 518-9708 (international), and reference passcode HRMYQ224. It is recommended that you dial in at least 10 minutes prior to the call.

The live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences 
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086 
cmccanless@harmonybiosciences.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-report-second-quarter-2024-financial-results-on-august-6-2024-302203230.html

SOURCE Harmony Biosciences

FAQ

When will Harmony Biosciences (HRMY) report its Q2 2024 financial results?

Harmony Biosciences (HRMY) will report its second quarter 2024 financial results on Tuesday, August 6, 2024, before the U.S. financial markets open.

What time is Harmony Biosciences' (HRMY) Q2 2024 earnings call scheduled for?

Harmony Biosciences' (HRMY) Q2 2024 earnings call is scheduled for Tuesday, August 6, 2024, at 8:30 a.m. ET.

How can investors participate in Harmony Biosciences' (HRMY) Q2 2024 earnings call?

Investors can participate in Harmony Biosciences' (HRMY) Q2 2024 earnings call by dialing (800) 225-9448 (domestic) or (203) 518-9708 (international) and using the passcode HRMYQ224.

Where can I find the webcast for Harmony Biosciences' (HRMY) Q2 2024 earnings call?

The live and replay webcast for Harmony Biosciences' (HRMY) Q2 2024 earnings call will be available on the investor page of the company's website at https://ir.harmonybiosciences.com/.